The most influential Megatrends set to shape the world through 2030, identified by Euromonitor International, help businesses better anticipate market developments and lead change for their industries.
Learn moreEuromonitor addresses your unique questions and challenges across all B2B and B2C industries and geographies through custom, tailor-made research projects, designed to your specific goals.
Learn moreMar 2019
US$1,325Added to Cart
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!
Growth of the global pharmaceuticals and medical equipment industry accelerated in 2018 on the back of strong performance of companies within Asia Pacific and Western Europe. Lucrative Asian markets, surging biologics production, and investment into innovative manufacturing are expected to ensure the category’s positive performance going forward. However, a deteriorating trade environment, and rising pricing pressures cloud the industry’s growth prospects.
Files are delivered directly into your account within a few minutes of purchase.
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.
Industry 4.0 is gradually entering the world of pharmaceutical production and is expected to steadily transform the way the industry operates. Companies already embrace Industry 4.0 solutions, including intelligent factories, highly integrated, flexible IT and manufacturing systems.
Ageing societies are expected to ensure continuous consumption of high-value-added drugs, especially in areas such as oncology and diabetes. Thus, biologics is set to be among the fastest growing pharmaceutical categories.
Production of biosimilars is expected to be spurred by the loss of patent protection for bestselling biologics, government support programmes, and strong Asian biosimilar companies entering the competitive landscape.
Rising demand for biologics and increasing need for patient- friendly solutions are anticipated to drive the strong growth of drug-device combination products.
Rising government pressure to curb healthcare costs will continue to manifest in regulatory pricing pressures for the pharmaceuticals industry.
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.